Kenley Emergency Medicine, et al. v. The Schumacher Group of Louisiana Inc., et al.

CourtDistrict Court, N.D. California
DecidedMarch 17, 2026
Docket3:20-cv-03274
StatusUnknown

This text of Kenley Emergency Medicine, et al. v. The Schumacher Group of Louisiana Inc., et al. (Kenley Emergency Medicine, et al. v. The Schumacher Group of Louisiana Inc., et al.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kenley Emergency Medicine, et al. v. The Schumacher Group of Louisiana Inc., et al., (N.D. Cal. 2026).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 KENLEY EMERGENCY MEDICINE, et Case No. 20-cv-03274-SI al., 8 Plaintiffs, ORDER GRANTING IN PART AND 9 DENYING IN PART DEFENDANTS’ v. MOTION TO DISQUALIFY COUNSEL 10 THE SCHUMACHER GROUP OF Re: Dkt. No. 189 11 LOUISIANA INC., et al.,

12 Defendants.

13 14 Before the Court is defendants’ motion to disqualify plaintiff-relator’s counsel Sanjiv N. 15 Singh, a Professional Law Corporation (“Singh”), and Phillips & Cohen LLP (“P&C”), and for other 16 relief. Dkt. No. 189 (“Mot.”). Defendants do not move to disqualify plaintiff-relator’s counsel, 17 Kessler Topaz Meltzer & Check LLP (“KTMC”). Relator opposes defendants’ motion. Dkt. Nos. 18 195 (“Singh Opp’n”), 196 (“KTMC Opp’n”), 197 (“P&C Opp’n”).1 Defendants filed a reply on 19 February 27, 2026. Dkt. No. 203 (“Reply”).2 For the reasons set forth below, the Court GRANTS 20 in part and DENIES in part defendants’ motion. 21 22 BACKGROUND 23 This motion arises out of a qui tam action originally filed on May 14, 2020 by plaintiff- 24 relator Kenley Emergency Medicine Corporations (“relator”) under the False Claims Act, 31 U.S.C. 25 1 In opposing the motion, each of relator’s counsel filed its own opposition brief. Many of 26 relator’s arguments are incorporated by reference into all of the briefs.

27 2 Relator also filed evidentiary objections to the supplemental reply declaration of Barry 1 § 3729, et seq. Dkt. No. 1. This factual and procedural background section is limited to facts relating 2 to the motion at issue. 3 Relator corporation is owned and operated solely by Dr. Eric Kenley, a board-certified 4 emergency physician. Dkt. No. 98 (“TAC”) ¶ 16. Dr. Kenley works at Chinese Hospital in San 5 Francisco which contracts with defendants, The Schumacher Group of Louisiana, d/b/a/ SCP Health 6 (“SCP”). Id. ¶ 17. Defendants “provide[] staffing and management services to hospitals and health 7 care facilities throughout the county.” Id. Relator alleges in its complaint that defendants have 8 engaged in “upcoding” which involves systematically charging for more expensive emergency room 9 healthcare than was actually provided to patients across the country. Id. ¶ 72. Singh represented 10 relator at the time the action was filed. Mot. at 8. 11 Beginning May 11, 2020, three days before the qui tam complaint was filed, Dr. Kenley 12 conveyed his upcoding concerns to various SCP executives, including a Group Medical Officer 13 (“GMO”) and an SCP “Compliance Officer.” Mot. at 8. The complaints were soon elevated to 14 SCP’s General Counsel & Chief Compliance Officer, Sarah Crass. Id. After relator filed the 15 original complaint on May 14, 2020 and while the action was under seal, a series of privilege issues 16 arose. Id.3 17 Defendants suggest that Singh played a role in orchestrating Dr. Kenley’s post-complaint 18 communications with SCP to intentionally generate privileged information. Id. at 11, 18, 21. Singh 19 denies involvement in this capacity. Id. at 11; Singh Opp’n at 3. 20 On May 28, 2020, Dr. Kenley joined a “Webex meeting with SCP to discuss responses to 21 his questions.” Mot. at 9.4 On June 3, 2020, Dr. Kenley communicated his concerns to SCP’s Chief 22 Medical Officer (“CMO”) by email. Id. at 9-10, Pollack Decl. Ex. 5. That same day, Dr. Kenley 23 emailed the CMO a letter he wrote to General Counsel explaining his concerns about SCP’s coding 24 and billing practices and requesting General Counsel’s “opinion,” “analysis and recommendation.” 25

26 3 Pursuant to False Claims Act procedures, the qui tam action was under seal until April 9, 2024. Dkt. No. 40. 27 1 Id. at 10, Pollack Decl., Ex. 6. Dr. Kenley continued to receive updates from the General Counsel 2 and the CMO, which defendants state included “privileged information about the compliance work 3 in progress being overseen by outside counsel.” Id. at 11-12. Some communications “described 4 consulting work being done under the supervision of outside counsel, and other potential work on 5 the processes, which outside counsel guided or supervised.” Id. On June 24, 2020, General Counsel 6 provided another written update to Dr. Kenley about SCP’s work with outside counsel. Id., Pollack 7 Decl., Ex. 10. In his communications with SCP personnel, Dr. Kenley did not reveal either the 8 pending qui tam action or that he was then represented by counsel. Id. at 11. 9 On June 30, 2020, September 14, 2020, and October 28, 2020, relator’s counsel sent three 10 supplemental disclosures to government agencies containing information Dr. Kenley gathered 11 through his conversations with SCP personnel. Id. at 11-12. On July 17, 2020, Singh filed the First 12 Amended Complaint. Id. at 12. On August 17, 2020, Singh filed the Second Amended Complaint 13 and referenced the May 28 Webex meeting with SCP in a footnote. Id.; Dkt. No. 16 ¶ 13. 14 General Counsel continued to communicate with Dr. Kenley about further updates through 15 at least September 24, 2020, when the CMO and General Counsel met with Dr. Kenley informing 16 him of certain business changes that SCP determined to make effective October 1, 2020. Mot. at 17 12. 18 Relator retained P&C as counsel in February 2021. P&C Opp’n at 2, Sylvia Decl. at ¶ 7. 19 During the intake process in late 2020 to early 2021, a P&C intake employee noticed that case 20 documents transmitted to P&C contained attorney communications. Mot. at 11-12. P&C states that 21 it “rejected the materials Singh sent because they contained reference to Defendants’ counsel.” P&C 22 Opp’n at 2. According to P&C, the rejected materials were never distributed to members of P&C, 23 and P&C does not have possession of them. Id. at 2-3. 24 As a result of this potential privilege issue5, in December, 2020 Singh met with Michael 25 Indrajana, his “own ethics counsel.” On or around January 15, 2021, Singh sequestered the attorney 26

27 5 On November 23, 2020, at an initial relator’s interview, the Department of Justice (“DOJ”) 1 communications with Indrajana as “walled counsel” (or “taint counsel”). Singh Opp’n at 3, Singh 2 Decl. ¶¶ 15-25, Indrajana Decl. ¶¶ 1-7. Indrajana and Singh share the same office space but operate 3 separate legal practices governed by a formal written agreement executed in 2017. Indrajana Decl. 4 ¶ 1, Singh Decl. ¶¶ 17-23. Also on January 15, 2021, Singh conducted a “claw back” of materials 5 he had provided to the government agencies in the three disclosures. Singh Decl. ¶¶ 15-16. 6 A Third Amended Complaint (“TAC”) was then filed on June 4, 2021, which also included 7 references to Dr. Kenley’s post-filing communications with SCP. Mot. at 13; TAC ¶¶ 83-88. 8 According to both Singh & P&C, P&C led the effort to draft and file the TAC. Singh Opp’n at 3, 9 Singh Decl. ¶¶ 10-14; P&C Opp’n at 3. P&C maintains that in drafting the TAC, “P&C did not 10 review, use, or refer to any disputed materials.” P&C Opp’n at 3. 11 On April 5, 2024, the United States declined to intervene in the qui tam action, and the Court 12 unsealed the matter a few days later. Mot. at 13. On September 4, 2025, defendants filed a motion 13 to seal and redact privileged communications from the TAC. Id. Relator assented and the Court 14 granted the motion. Id. Relator’s counsel did not inform defendants or the Court of the government 15 claw back or of the existence of walled off counsel. Id. 16 In early September 2025, the alleged privilege issues came to light after defendants filed 17 public records requests with the government agencies to which relator had made submissions. Id. 18 at 14-16. The public records requests revealed that on January 15, 2021, relator’s counsel had 19 requested to claw back certain disclosures counsel had made to a government agency while the case 20 was under seal. Id. at 14.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
United States v. Graf
610 F.3d 1148 (Ninth Circuit, 2010)
American Civil Liberties Union v. Holder
673 F.3d 245 (Fourth Circuit, 2011)
In Re Bieter Company
16 F.3d 929 (Eighth Circuit, 1994)
In Re: County Of Los Angeles
223 F.3d 990 (Ninth Circuit, 2000)
United States v. Ruehle
583 F.3d 600 (Ninth Circuit, 2009)
Lopez v. City of Oxnard
207 Cal. App. 3d 1 (California Court of Appeal, 1989)
Rico v. Mitsubishi Motors Corp.
171 P.3d 1092 (California Supreme Court, 2007)
People v. Moronati
232 P. 991 (California Court of Appeal, 1924)
United States v. Sanmina Corporation
968 F.3d 1107 (Ninth Circuit, 2020)
Irving v. Carpentier
11 P. 391 (California Supreme Court, 1886)
Clark v. Superior Court
196 Cal. App. 4th 37 (California Court of Appeal, 2011)
Beltran v. Avon Products, Inc.
867 F. Supp. 2d 1068 (C.D. California, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Kenley Emergency Medicine, et al. v. The Schumacher Group of Louisiana Inc., et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kenley-emergency-medicine-et-al-v-the-schumacher-group-of-louisiana-cand-2026.